Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Battle of the ALKs: ALK IHC vs. ISH in treatment of ALK-positive advanced NSCLC Prof Dr EMD (Ed) Schuuring & Prof Dr HJM (Harry) Groen Join Dr. Ed Schuuring and Dr. Harry Groen, University Medical Center Groningen, The Netherlands, to explore the role of immunohistochemistry (IHC) in ... 4 years ago | 56 mins ALK IHC vs ISH and ALK Inhibitors in Treatment of ALK-Positive Advanced NSCLC Prof Dr EMD (Ed) Schuuring and Prof Dr HJM (Harry) Groen ALK IHC vs ISH and ALK Inhibitors in Treatment of ALK-Positive Advanced NSCLC presented by Prof Dr. EMD (Ed) Schuuring, Clinical Scientist in Molecula... 4 years ago | 32 mins ROS1 in NSCLC Pathology and Prediction Dr. Erik Thunnissen, FBJM ROS1 in NSCLC Pathology and Prediction presented by Dr. Erik Thunnissen, FBJM, Department of Pathology, VU University Medical Center Amsterdam, The Ne... 4 years ago | 12 mins Immunotherapy biomarkers: friends or foes? Professor Keith Kerr, MB, ChB, FRCPath, FRCPE, Consultant Pathologist, Department of Pathology, University of Aberdeen, Aberd Immunotherapy is changing the cancer care paradigm: for a small but significant group of patients, cancer has become a chronic disease and immunothera... 6 years ago | 60 mins
